In silico mutation analysis of TAR DNA binding protein-43 causing fronto temporal lobar degeneration | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


In silico mutation analysis of TAR DNA binding protein-43 causing fronto temporal lobar degeneration

Author(s): Sree Vishnupriya K. and Rajasekaran R.*

The most detrimental missense mutations of TAR DNA Binding Protein 43 causing Fronto Temporal Lobar Degeneration were identified computationally and the substrate binding efficiencies of these mutations were analyzed. Out of 24 variants, I-Mutant 2.0, SIFT and PolyPhen programs identified 1 variant (D169G) that was less stable, deleterious and damaging respectively. Modeling of this one variant was performed to understand the change in their conformations with respect to the native TAR DNA Binding Protein 43 by computing their RMSD and Total energy. The native and the variant were docked with RNA to explain the binding efficiencies of those detrimental missense mutations. The loss of binding affinity with their interacting protein namely RNA was investigated by computing the flexibility of binding amino acids of TAR DNA Binding Protein 43 with their interacting proteins and computing the binding free energy (ΔG) between native and mutant complexes. The novelty of our work is to identify and validate the detrimental missense mutations based on structural stability which could be reliable and competent with other computational programs.


Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry